Uruguay

Cognitive assessment is routinely performed in clinical settings (primary care, geriatrics and neurology clinics and neuropsychology services) using standard brief instruments such as the MMSE and increasingly the MoCA (both used in Uruguayan studies and clinical practice) and by more detailed neuropsychological batteries in specialist centres. Local publications and the MSP recommendations emphasise multidisciplinary assessment rather than mass screening.

The national recommendations are explicitly oriented toward improving diagnostic timeliness and clinical decision-making within the existing SNIS infrastructure. Structural neuroimaging, Computed Tomography (CT) or Magnetic Resonance Imaging (MRI), is considered part of the standard differential diagnostic process when clinically indicated, particularly to exclude secondary causes or support subtype differentiation. Access to imaging is therefore embedded within the general health system, rather than organised through dementia-specific diagnostic hubs. However, practical availability varies by provider capacity, contractual arrangements, and geographic location.

There is no evidence of a nationally standardised pathway for genetic testing in dementia care in Uruguay, including APOE genotyping or testing for monogenic forms of dementia. Genetic investigations, where they occur, are most likely specialist-led and case-specific, typically reserved for early-onset cases, strong family histories, or atypical clinical presentations.

While biomarker-based diagnosis (cerebrospinal fluid (CSF) or blood biomarkers) is expanding in parts of Latin America, the reviewed sources provide no Uruguay-specific evidence of standardised national Alzheimer’s disease biomarker pathways being incorporated into routine clinical care. Use of biomarkers, where available, appears to be centre-dependent, likely limited to research contexts or highly specialised clinical settings. This suggests that Uruguay’s dementia diagnostic model remains clinically driven, relying on history, cognitive assessment, and structural imaging rather than molecular confirmation. While this may limit early or etiological precision in some cases, it is consistent with the country’s emphasis on system-wide accessibility and equity, avoiding reliance on diagnostics that are not uniformly available across SNIS providers.

Uruguay’s national Recommendations for the Comprehensive Approach to Dementia explicitly conceptualise dementia care as an interdisciplinary, longitudinal process rather than a discrete episode of specialist intervention. The guidance stresses the need for continuous and progressive attention, integrating medical follow-up with psychosocial support, functional assessment, and planning for increasing dependency. Importantly, the document also calls for articulation beyond the health sector, recognising that effective dementia care necessarily extends into social services, community resources, and the broader care system, a framing that aligns dementia with ageing and dependency policy rather than isolating it within neurology or psychiatry alone.

In practical terms, Uruguay does not rely on a dense network of stand-alone memory clinics. Instead, dementia-related services are embedded within SNIS provider networks, with interdisciplinary responses assembled through combinations of primary care, specialists, mental health services, rehabilitation professionals, and social workers.

Specialised memory assessment and dementia care in Uruguay are concentrated in Montevideo, particularly in national referral centres such as the Hospital de Clínicas (with neuropsychology and neurology services) and private memory clinics. These services provide diagnostic evaluation, cognitive testing and specialist follow-up. Outside the capital, access to multidisciplinary memory clinics is more limited, and patients in smaller cities or rural departments often need referral or travel to Montevideo or other main urban centres for comprehensive assessment.

Day and community support services are more geographically distributed but vary in scope and intensity. The Asociación Uruguaya de Alzheimer y Similares (AUDAS) operates a dedicated Alzheimer day centre in Montevideo and has regional filials (e.g., in Salto), offering caregiver support and community activities. In addition, the national Sistema de Cuidados supports Centros de Día for older adults across multiple departments. However, the availability of specialised dementia-focused programming, professional staffing and service hours differs by locality, with stronger provision in Montevideo and larger cities.

Uruguay has an established National Palliative Care Programme under the Ministry of Health, with hospital-based teams and some home-care models intended to serve patients across the country, including those with advanced dementia. Coverage has expanded beyond the capital, but access and team capacity remain stronger in major hospitals and urban centres. Rural areas may rely on general health services with referral links to regional or Montevideo-based palliative teams.

Civil society plays a complementary and often highly visible role. In particular, AUDAS, based in Montevideo, functions as a practical navigation and support hub for families, providing information, counseling, caregiver guidance, and links to available services. This NGO presence helps bridge gaps between formal policy intent and families’ real-world experience of fragmented pathways, especially during the transition from diagnosis to longer-term care planning.

The cost profile of dementia care in Uruguay is shaped primarily by whether patients and families are able to remain within SNIS provider networks or choose (or feel compelled) to supplement care through private services. Core medical components, consultations, basic diagnostics, and standard treatments, are generally covered within the integrated system, supporting a relatively strong baseline of financial protection by regional standards. However, the largest economic burden emerges over time and falls disproportionately on households. These costs include informal caregiving time, transport to appointments, particularly from the interior to Montevideo, home adaptations, and productivity losses for family members. When waiting times or service gaps lead families to seek private diagnostics or therapies, out-of-pocket spending increases, introducing socioeconomic gradients in care experience despite universalist policy design. Dementia thus remains a condition where formal health coverage moderates but does not eliminate financial strain.

Government documentation defines the National System of Integrated Care (SNIC) as a coordinated set of public and private actions aimed at supporting people with dependency in activities of daily living, a framework that becomes increasingly relevant as dementia progresses from cognitive impairment to functional dependence. Although not dementia-specific, the system provides a structural platform for home-based care, support services, and recognition of caregiving needs.

Programa de Apoyo al Cuidado Permanente (PACP) offers a subsidy for long-term care support, which can indirectly aid caregivers of older adults who may include people living with dementia.

Complementing this, Recommendations for the Comprehensive Approach to Dementia explicitly recognise caregiver support as an integral component of the dementia response, including guidance, education, and psychosocial support strategies. This dual anchoring, within both dementia-specific clinical guidance and the broader care system, signals an advanced conceptual understanding of dementia as a family and social condition, not merely a medical diagnosis. The main challenge lies in operational reach and scalability, particularly outside Montevideo, but institutionally Uruguay has laid groundwork that many regional peers have yet to establish.

Uruguay officially launched its National Dementia Plan (Plan Nacional de Demencia) on March 9, 2023. Developed by the Ministry of Public Health in collaboration with the Asociación Uruguaya de Alzheimer y Similares (AUDAS) and Alzheimer’s Disease International, the plan aims to address the growing public health challenge of cognitive decline through seven key areas. These include improving timely diagnosis, enhancing specialised care and support for both patients and caregivers, and promoting public awareness to reduce the social stigma surrounding the disease.

Innovation in Uruguay’s dementia response is most evident at the level of system organisation and standardised clinical practice, rather than novel diagnostics or therapeutics. The national Recommendations for the Comprehensive Approach to Dementia represent a deliberate innovation in governance: a nationally endorsed, multidisciplinary guide explicitly designed to change day-to-day practice across all levels of care, particularly strengthening primary care recognition, referral, and coordination. This form of innovation prioritises feasibility, equity, and scalability within the SNIS. By focusing on interdisciplinary workflows, caregiver inclusion, and continuity of care, Uruguay’s approach innovates through process and integration, aligning dementia care with broader health system reform rather than relying on high-technology or specialist-only models.

A public polyclinic in the town of San Bautista, in Canelones, illustrates how Uruguay’s health system reform translated universal health coverage into effective primary care at the local level. Following the launch of reforms to the SNIS the facility evolved from a setting with limited medicines, no on-site laboratory, and fragmented care into a community-based primary care hub providing essential medicines, laboratory services, basic medical specialties, home visits, and coordinated referrals with hospitals. Serving a largely older population in a rural context with limited transport options, the polyclinic emphasises continuity of care and comprehensive, person-centred practice that integrates medical, psychological, and social dimensions. Managed by the State Health Services Administration and linked to the University of the Republic for training and workforce development, the polyclinic has become a trusted access point for a significant share of local residents. Its model, combining strong primary care, community outreach, and equitable access regardless of income, has been highlighted by national and international health institutions as an example of good practice. The experience reflects Uruguay’s broader universal health strategy, under which coverage expanded substantially through the National Health Fund, reinforcing the role of strengthened primary care as the foundation of an integrated and inclusive health system.

A study from January 2025 examined 73 cognitively healthy, highly educated adults from the Uruguayan cohort of the LatAm FINGERS project to explore how ApoE genotype relates to cognitive performance and dementia risk factors. Participants underwent ApoE genotyping, standardised cognitive testing, and assessment of vascular and lifestyle risk factors. Only one individual carried the high-risk ApoE ε4/ε4 genotype and was excluded from group analyses. Results showed significant differences in CERAD total and CERAD delayed recall scores across ApoE allele combinations, indicating that even among cognitively normal individuals, genetic variation is associated with subtle differences in memory performance. No significant differences were observed in other cognitive domains. Higher educational level correlated positively with CERAD scores and negatively with functional and depressive measures (CDR, GDS), while vascular risk correlations aligned between Framingham and CAIDE risk scores. Overall, the findings suggest that ApoE-related cognitive variability is detectable before clinical impairment in an underrepresented, high-education population, underscoring the importance of incorporating genetic factors into multidomain dementia-prevention and ageing-research frameworks, even among cognitively.